Fabian Gerlinghaus
Co-Founder & Chief Executive Officer Cellares
Seminars
Wednesday 16th September 2026
Delivering Commercial-Ready Cell Therapies at Scale through a Global Network of Smart Factories
8:55 am
- Case study: successful manufacturing of a clinical-stage CAR-T drug product using the Cellares Cell Shuttle
- Breaking the QC bottleneck with high-throughput, digitally integrated release testing via Cell Q
- Standardizing automation-native facility design across the US, EU, and Japan
